Walleye Capital
SNY icon

Walleye Capital’s Sanofi SNY Stock Holding History

Walleye Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$887K Sell
18,400
-83,100
-82% -$3.87M ﹤0.01% 2188
2025
Q4 		$4.92M Buy
101,500
+69,800
+220% +$3.46M 0.02% 1163
2025
Q3 		$1.5M Buy
31,700
+14,100
+80% +$680K 0.01% 1793
2025
Q2 		$850K Buy
17,600
+7,900
+81% +$404K ﹤0.01% 2178
2025
Q1 		$538K Sell
9,700
-96,400
-91% -$5.22M ﹤0.01% 2501
2024
Q4 		$5.12M Buy
106,100
+47,200
+80% +$2.4M 0.01% 1051
2024
Q3 		$3.39M Buy
58,900
+53,700
+1,033% +$2.9M 0.01% 1472
2024
Q2 		$252K Buy
+5,200
New +$251K ﹤0.01% 4123
2024
Q1 		– Sell
-54,800
Closed -$2.73M – 5866
2023
Q4 		$2.73M Sell
54,800
-6,400
-10% -$313K 0.01% 1552
2023
Q3 		$3.28M Buy
61,200
+55,900
+1,055% +$2.98M 0.01% 1356
2023
Q2 		$286K Buy
5,300
+600
+13% +$32.3K ﹤0.01% 2842
2023
Q1 		$256K Buy
+4,700
New +$229K ﹤0.01% 2253

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Walleye Capital's SNY Position: Q1 2026 in Review

Walleye Capital increased its Sanofi (SNY) stake by 441,700% in Q1 2026, buying an estimated $206K and bringing the position to 4,418 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #3311.

Walleye Capital first reported a position in SNY in Q3 2018 and has held it in 11 quarters since. The position peaked at $9.38M in Q3 2023. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Walleye Capital held 4,418 shares of Sanofi worth $213K as of Q1 2026.
  • Walleye Capital bought 4,417 Sanofi shares in Q1 2026, an estimated $206K.
  • Sanofi made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3311 holding.
  • Walleye Capital first reported a position in Sanofi in Q3 2018 and has held it in 11 quarters since.
  • Walleye Capital's Sanofi position peaked at $9.38M in Q3 2023.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.